Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform

The COVID-19 pandemic has reached over 100 million worldwide. Due to the multi-targeted nature of the virus, it is clear that drugs providing anti-COVID-19 effects need to be developed at an accelerated rate, and a combinatorial approach may stand to be more successful than a single drug therapy. Am...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakravarty, Kaushik, Antontsev, Victor G., Khotimchenko, Maksim, Gupta, Nilesh, Jagarapu, Aditya, Bundey, Yogesh, Hou, Hypatia, Maharao, Neha, Varshney, Jyotika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037385/
https://www.ncbi.nlm.nih.gov/pubmed/33805419
http://dx.doi.org/10.3390/molecules26071912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037385/
https://www.ncbi.nlm.nih.gov/pubmed/33805419
http://dx.doi.org/10.3390/molecules26071912

Ejemplares similares